FdaApplication
NDA 210795
Identifiers
- fda_app_no: NDA210795
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND |
| application_type | NDA |
| approval_date | 2018-07-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KRINTAFEL | TAFENOQUINE SUCCINATE | EQ 150MG BASE | TABLET;ORAL |
1 product